KeyBanc raised the firm’s price target on Encompass Health (EHC) to $117 from $115 and keeps an Overweight rating on the shares. The firm says Q3 results look really strong, highlighted by a 4% EBITDA beat driven by stronger SS volumes. KeyBanc continues to favor Encompass Health’s stock given strong fundamentals and insulation from election-related dynamics.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EHC: